Integrated Diagnostics Holdings plc (LON:IDHC)

London flag London · Delayed Price · Currency is GBP · Price in USD
0.600
0.00 (0.00%)
Apr 28, 2026, 4:35 PM GMT
66.67%
Market Cap 257.43M
Revenue (ttm) 122.36M
Net Income (ttm) 19.66M
Shares Out 581.33M
EPS (ttm) 0.03
PE Ratio 13.18
Forward PE 11.03
Dividend 0.01 (1.42%)
Ex-Dividend Date May 28, 2026
Volume 45,812
Average Volume 140,890
Open 0.602
Previous Close 0.600
Day's Range 0.572 - 0.610
52-Week Range 0.320 - 0.830
Beta 0.38
RSI 46.24
Earnings Date Sep 2, 2026

About LON:IDHC

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog... [Read more]

Sector Healthcare
Founded 1979
Employees 6,309
Stock Exchange London Stock Exchange
Ticker Symbol IDHC
Full Company Profile

Financial Performance

In 2025, LON:IDHC's revenue was 7.86 billion, an increase of 37.34% compared to the previous year's 5.72 billion. Earnings were 1.26 billion, an increase of 17.15%.

Financial numbers in EGP Financial Statements

News

There is no news available yet.